Search company, investor...

Transport Pharmaceuticals

transportpharma.com

Founded Year

1999

Stage

Series D | Alive

Total Raised

$39.6M

Last Raised

$39.6M | 16 yrs ago

About Transport Pharmaceuticals

Transport Pharmaceuticals is developing a drug/device platform for the treatment of dermatological diseases

Headquarters Location

161 Worcester Road Suite 402

Framingham, Massachusetts, 01701,

United States

508-872-0433

Missing: Transport Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Transport Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Transport Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Transport Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Transport Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Transport Pharmaceuticals founded?

    Transport Pharmaceuticals was founded in 1999.

  • Where is Transport Pharmaceuticals's headquarters?

    Transport Pharmaceuticals's headquarters is located at 161 Worcester Road, Framingham.

  • What is Transport Pharmaceuticals's latest funding round?

    Transport Pharmaceuticals's latest funding round is Series D.

  • How much did Transport Pharmaceuticals raise?

    Transport Pharmaceuticals raised a total of $39.6M.

  • Who are the investors of Transport Pharmaceuticals?

    Investors of Transport Pharmaceuticals include The Carlyle Group, EGS Healthcare Capital Partners, The Hillman Company, Quaker BioVentures, EGS Private Healthcare Partnership and 3 more.

  • Who are Transport Pharmaceuticals's competitors?

    Competitors of Transport Pharmaceuticals include Diasome Pharmaceuticals, Reata Pharmaceuticals, Bellicum Pharmaceuticals, Intercept Pharmaceuticals, Halscion and 10 more.

Compare Transport Pharmaceuticals to Competitors

T
Tioga Pharmaceuticals

Tioga Pharmaceuticals, is focused on the development of therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline in Phase 3 clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome (D-IBS). The company was founded in 2005 and is based in San Diego, California.

A
Ausio Pharmaceuticals

Ausio Pharmaceuticals is a company focused on the clinical development of S-Equol for major medical needs.

M
Marillion Pharmaceuticals

Marillion Pharmaceuticals, Inc. - Marillion is developing clinical-stage drugs in oncology and oncology supportive care. 177Lu-AMBA is a targeted radiotherapeutic, with the low level radiation of lutetium that aims to utilize an receptor-based technology, and can serve as both a diagnostic and therapeutic agent. The targeting capability means that 177Lu-AMBA homes in on tumor cells and spares normal tissues. 177Lu-AMBA is being pursued initially to treat hormone-resistant prostate cancer, has been studied in a phase I trial in Europe. Marillion also is developing PilobucTM , buccal formulation of pilocarpine ,for the treatment of dry mouth, shown in clinical trials to effectively and conveniently deliver the drug with reduced side effects compared to other routes of administration.PilobucTM buccal formulation of pilocarpine has the potential to be a product in the xerostomia market. Marillion is preparing for phase II trials of the product candidate..

S
Sequoia Pharmaceuticals

Sequoia Pharmaceuticals, Inc. is engaged in the discovery and development of antiviral therapeutics, with a focus on developing new treatments for drug-resistant infectious diseases such as HIV/AIDS and HCV-induced hepatitis. Sequoia Pharmaceuticals is located in Gaithersburg, Md.

I
Inagen Aps

Inagen was formed in 2007 to develop therapies for viral diseases. The company's primary candidate is treatment for Cytomegalovirus (CMV). There is a great unmet need for effective treatment to eradicate this serious disease.

I
ISW Group

ISW Group is a pharmaceutical company that researches and aims to develop FDA approved topical products for the management and treatment of acute and chronic inflammatory skin conditions. ISW Group's research program focuses on acute and chronic dermatologic irritation and inflammation associated with dermatitis, Pseudofolliculitis barbae, burn care and wound healing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.